Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Pharmacoeconomics|March 3, 2001
Effectiveness of eletriptan in reducing time loss caused by migraine attacksN E Wells, T J SteinerFunctional Neurology|February 24, 2001
The relevance and application of disease management and pharmacoeconomics to migraineN E WellsCephalalgia : an International Journal of Headache|October 1, 1995
Long-term cost-benefit assessment of anti-migraine drugsT J SteinerJournal of Cardiovascular Pharmacology|January 1, 1990
Naftidrofuryl after acute stroke: a review and a hypothesisT J SteinerCephalalgia : an International Journal of Headache|April 9, 1998
Treating headache from an evidence base: the Cochrane CollaborationT J SteinerCephalalgia : an International Journal of Headache|September 13, 2014
What efficacy measures are clinically relevant and should be used in Cochrane reviews of acute migraine trials? An alternative viewpointT J SteinerLancet (London, England)|June 15, 1991
Abrupt outpatient withdrawal of medication in analgesic-abusing migraineursR Hering, T J SteinerCephalalgia : an International Journal of Headache|May 28, 1998
Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg)T J Steiner, R LangeJournal of Clinical Pharmacy and Therapeutics|March 3, 2009
Gastrointestinal tolerability of aspirin and the choice of over-the-counter analgesia for short-lasting acute painT J Steiner, M VoelkerPageof 8